Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_1223 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_1223 |
| Peptide Name | D-penetratin |
| PEPTIDE SEQUENCE (1-letter) | RQIKIWFQNRRMKWKK |
| PEPTIDE SEQUENCE (3-letter) | NA |
| N-terminal modification | NA |
| C-terminal modification | NA |
| Chemical modification | NA |
| Peptide Length | 16 |
| Conformation | NA |
| Peptide Nature | NA |
| Source/Origin of peptide | Chemically synthesized |
| SMILES | NA |
| Cell Line | In situ brain perfusion technique |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | Capillary depletion method |
| In vitro RESULT | Vectorization of dox led to a 20-fold increase in the amount of dox transportation. |
| ANIMAL MODEL | Male Sprague-Dawley rats |
| In vivo CONCENTRATION | 2.5 mg/kg |
| In vivo MODE OF DELIVERY | Intravenous |
| In vivo METHOD | Capillary depletion method |
| In vivo RESULT | It led to a significant increase in brain dox concentrations during the first 30 min of postadminist |
| ACTION | The use of these peptide vectors for brain delivery of dox. |
| TRANSPORT TYPE | Transcytosis |
| SUBCELLULAR LOCALISATION | Brain parenchyma |
| COMBINATION | Combined with Doxorubicin |
| PHYSICAL CONDITION | NA |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 10727512 |